EOLS
Evolus, Inc.
Industry
Drug Manufacturers - Specialty & Generic
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Loading...
Open
11.50
Mkt cap
723M
Volume
293K
High
11.80
P/E Ratio
-12.55
52-wk high
17.82
Low
11.41
Div yield
N/A
52-wk low
9.65

Portfolio Pulse from Benzinga Newsdesk
September 16, 2024 | 12:24 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.